240 related articles for article (PubMed ID: 4615350)
1. [Biotransformation of drugs by the liver].
González Macias JG
Rev Clin Esp; 1974 Nov; 135(3):207-18. PubMed ID: 4615350
[No Abstract] [Full Text] [Related]
2. Adaptive responses of the liver to foreign compounds, with special reference to microsomal drug-matabolizing enzymes.
Wada O; Yano Y
Rev Environ Health; 1974; 1(4):261-82. PubMed ID: 4617260
[No Abstract] [Full Text] [Related]
3. Refresher courses in pharmacology. 4. The biotransformation of drugs.
Jenkins WL
J S Afr Vet Med Assoc; 1971 Sep; 42(3):211-6. PubMed ID: 5161402
[No Abstract] [Full Text] [Related]
4. [Liver and metabolism of drugs].
Darnis F
Cah Med; 1974 Oct; 15(10):637-43. PubMed ID: 4455367
[No Abstract] [Full Text] [Related]
5. [Effect of various physiological and pathological conditions on the bioavailability of drugs].
Danysz A; Wierzba K
Pol Tyg Lek; 1979 Jan; 34(4):141-3. PubMed ID: 432125
[No Abstract] [Full Text] [Related]
6. [Biotransformation of drugs].
Lechat P
Farmaco Sci; 1972 Mar; 27(3):240-56. PubMed ID: 4623305
[No Abstract] [Full Text] [Related]
7. [Dose adaptation of drugs for liver patients using a simple risk classification].
Zysset T; Bircher J
Internist (Berl); 1983 Mar; 24(3):151-61. PubMed ID: 6347941
[No Abstract] [Full Text] [Related]
8. Effects of nutrition on drug metabolism and distribution.
Woods HF
Compr Ther; 1978 Oct; 4(10):49-53. PubMed ID: 359231
[No Abstract] [Full Text] [Related]
9. [Role of liver in the metabolism of drugs (literature review)].
Mansurova ID
Sov Med; 1973 Nov; 36(11):83-7. PubMed ID: 4595463
[No Abstract] [Full Text] [Related]
10. [Genetic polymorphism of the hepatic metabolism of drugs].
Larrey D; Pessayre D; Benhamou JP
Gastroenterol Clin Biol; 1985; 9(6-7):522-31. PubMed ID: 3926587
[No Abstract] [Full Text] [Related]
11. Aspects of drug metabolism relating to pharmacologic activity.
Gillette JR
Am J Pharm Sci Support Public Health; 1969; 141(2):64-75. PubMed ID: 4979429
[No Abstract] [Full Text] [Related]
12. [Drug metabolism in newborn infant (author's transl)].
Abucewicz A; Szyszka K
Przegl Lek; 1973; 30(7):596-9. PubMed ID: 4583911
[No Abstract] [Full Text] [Related]
13. The disposition and effects of sedatives and analgesics in liver disease.
Hoyampa AM; Branch RA; Schenker S
Annu Rev Med; 1978; 29():205-18. PubMed ID: 348033
[No Abstract] [Full Text] [Related]
14. Clearance by the liver: current concepts in understanding the hepatic disposition of drugs.
Larrey D; Branch RA
Semin Liver Dis; 1983 Nov; 3(4):285-97. PubMed ID: 6359424
[No Abstract] [Full Text] [Related]
15. [Clinical pharmacologic aspects of cytochrome P-450 dependent biotransformation of drugs].
Ackermann E
Pharmazie; 1978 Jul; 33(7):400-6. PubMed ID: 364493
[No Abstract] [Full Text] [Related]
16. [Pharmacogenetics, its achievements and perspectives (review of the literature)].
Skakun NP
Vrach Delo; 1974 Mar; (3):1-4. PubMed ID: 4619733
[No Abstract] [Full Text] [Related]
17. Binding of drugs to serum albumin (first of two parts).
Koch-Weser J; Sellers EM
N Engl J Med; 1976 Feb; 294(6):311-6. PubMed ID: 1107839
[No Abstract] [Full Text] [Related]
18. [Characteristics of drug therapy in kidney and liver insufficiency, in infancy and old age, during pregnancy and lactation].
Rameis H
Wien Med Wochenschr; 1983 Mar; 133(6):141-51. PubMed ID: 6858179
[No Abstract] [Full Text] [Related]
19. Sounding board. Why are toxic reactions to drugs so often undetected initially?
Vesell ES
N Engl J Med; 1980 May; 302(18):1027-9. PubMed ID: 6767974
[No Abstract] [Full Text] [Related]
20. Fetal and neonatal pharmacology.
Yaffe SJ
Clin Perinatol; 1974 Mar; 1(1):39-45. PubMed ID: 4470047
[No Abstract] [Full Text] [Related]
[Next] [New Search]
